Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
SpainLong‑Term Safety and Efficacy Study of ENTR‑601‑45 and ENTR‑601‑44 in Participants with Duchenne Muscular Dystrophy
SpainDuchenne Muscular Dystrophy in Patients with Gene Mutations Amenable to Exon 44 Skipping Treated with Delpacibart Zotadirsen
SpainA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
SpainA study to evaluate the safety and effectiveness of surlorian in adults with RYR1-related myopathy
SpainA study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.
SpainA Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease
SpainA study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy
SpainA Study Testing AOC 1020 to Improve Movement in Adults with Facioscapulohumeral Muscular Dystrophy
SpainStudy of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease
SpainStudy of intravenous AOC 1001 to evaluate long-term safety and effectiveness in patients with myotonic dystrophy type 1
SpainStudy on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I
Spainpowered by
